273 results on '"Agbor-Enoh S"'
Search Results
2. Cell-Free DNA Exposes Tissue Injury Profiles Leading to Primary Graft Dysfunction
3. Plasma Cell-Free DNA Chromatin Immunoprecipitation Distinguishes Acute Rejection Subtypes After Heart Transplantation
4. A Molecular Criteria for Antibody Mediated Rejection in Lung Transplant Recipients is Associated with an Increased Risk of the Composite Outcome of CLAD and Death
5. Genomic Research Alliance for Transplantation GRAfT: A Model to Access Patients and Promote NHLBI DIR Research
6. Association of Donor-Derived Cell-Free DNA Levels with the Development of De Novo Donor-Specific Antibodies and Risk of Death in Lung Transplant Recipients
7. Cell-Free DNA to Unveil Potential Mechanisms of Racial Disparities in Lung Transplant
8. Multiplexing Droplet Digital PCR Assays to Detect Allograft Injury in Lung Transplant Recipients
9. (220) Cell-Free DNA Enhances Pathologist Interrater Reliability at the Assessment of Acute Rejection on Endomyocardial Biopsy, on Behalf of the GRAfT Investigators
10. (1187) Study Design for a Randomized Control Trial of Lung Allograft Monitoring with Blood Donor-Derived Cell-Free DNA Assessments (LAMBDA 001)
11. (130) Dysregulated Circulating Proteins in Cellular and Antibody-Mediated Rejection, on Behalf of the Graft Investigators
12. Elevated Cell Free DNA in Respiratory Viral Infection and Associated Lung Allograft Dysfunction
13. Restrictive Allograft Syndrome Patients Have Higher Cell-Free DNA Assessed Allograft Injury Prior to Diagnosis
14. Pleuroparenchymal Fibroelastosis in Chronic Graft-versus-Host-Disease
15. Comparative Performance Analysis of Donor-Derived Cell-Free DNA to Detect Acute Rejection in Single and Double Lung Transplant Recipients
16. Is Acute Rejection Truly Acute or an Exacerbation of an Underlying Disease?
17. Genome-Wide DNA Methylation Analysis to Define Pulmonary Antibody-Mediated Rejection (AMR) Treatment Response
18. Pseudomonas aeruginosa Elicits Sustained IL-1β Upregulation in Alveolar Macrophages from Lung Transplant Recipients
19. Cell-Free DNA to Distinguish High Risk Donor Specific Antibodies in Heart Transplantation
20. Absolute versus Percent of Donor-Derived Cell-Free DNA to Detect Lung Transplantation Rejection
21. Circulating microRNA Biomarkers in Cellular and Antibody-Mediated Heart Transplant Rejection
22. The ISHLT CLAD Consensus is Broadly Applicable in Stem Cell Transplant
23. Secondary Bacterial and Fungal Pneumonia Complicating SARS-CoV-2 and Influenza Infections in Lung Transplant Recipients
24. Genome-Wide Cell-Free DNA Methylation Analysis Reveals Significant Recipient Tissue Injury in Allograft Rejection
25. (1306) - Genomic Research Alliance for Transplantation GRAfT: A Model to Access Patients and Promote NHLBI DIR Research
26. (702) - Cell-Free DNA Exposes Tissue Injury Profiles Leading to Primary Graft Dysfunction
27. (659) - Cell-Free DNA to Unveil Potential Mechanisms of Racial Disparities in Lung Transplant
28. (620) - Association of Donor-Derived Cell-Free DNA Levels with the Development of De Novo Donor-Specific Antibodies and Risk of Death in Lung Transplant Recipients
29. (367) - Multiplexing Droplet Digital PCR Assays to Detect Allograft Injury in Lung Transplant Recipients
30. (340) - Plasma Cell-Free DNA Chromatin Immunoprecipitation Distinguishes Acute Rejection Subtypes After Heart Transplantation
31. (201) - Cell-Free DNA Identifies High-Risk Donor Specific Antibodies in Heart Transplant Recipients
32. (59) - Myocardial Offloading with a Left Ventricular Assist Device Reduces End Organ Injury
33. (51) - A Molecular Criteria for Antibody Mediated Rejection in Lung Transplant Recipients is Associated with an Increased Risk of the Composite Outcome of CLAD and Death
34. Impact of AMR Treatment: Responders vs Non-Responders Characteristics
35. Biological Variation of Donor-Derived Cell-Free DNA in Lung Transplant Recipients
36. Racial Differences in Immunosuppression and Lung Transplant Outcomes
37. Cell Free DNA Levels in Patients with Acute Rejection after Lung Transplantation
38. Telemedicine with a Cell-Free DNA Based Monitoring Approach Maintains Lung Allograft Function While Reducing Frequency of Invasive Bronchoscopy
39. Performance of Donor Derived Cell-Free DNA in Routine Clinical Care of Lung Transplant Recipients, a Multi-Center Study
40. Cell-Free DNA Tissue Damage Mapping in Transplant Patients Infected with COVID-19
41. Cell-Free DNA to Monitor Immunosuppression Adequacy in Lung Transplantation
42. Cardiac Allograft Injury in Patients of African Ancestry: Trends of Donor-Derived Cell-Free DNA Based on Genetic Ancestry
43. Increased Cell Free DNA Levels in African American Patients Early after Heart Transplantation
44. (1207) Anellovirus: A Novel Marker for Overimmunosuppression and Risk of Infection in Lung Transplant Recipients
45. Gastrointestinal: A worm in a cocoon: an unusual presentation of encapsulating peritoneal sclerosis
46. Allograft Injury and Outcomes in African American Lung Transplant Recipients
47. Improved Survival after Repeat Lung Transplantation at Cystic Fibrosis Care Centers
48. The Impact of Gastroesophageal Reflux and Esophageal Motility on Spirometry Following Lung Transplantation
49. Characterization of Respiratory Pathogens in Contemporary Lung Transplant Recipients
50. Clinical Outcomes after Pediatric Lung Transplantation at Cystic Fibrosis Care Centers
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.